Skip to main content
Fig. 3 | Human Genomics

Fig. 3

From: 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease

Fig. 3

Scatterplot between the semi-quantitative assessment of T1 (atrophy) and STIR (muscle oedema): the size of the circle displays the number of muscle regions. Most muscle regions showed no atrophy (T1 = 0) and no oedema (STIR = 0). As atrophy increases so does muscular oedema, but only up to a score of T1 = 2. From there, further atrophy is associated with less oedema. Of note, some muscles showing no atrophy (T1 = 0) already exhibited oedema, possibly an early sign of affected muscle

Back to article page